Summary
There is great need for more effective bone grafts to treat craniomaxillofacial (CMF) complications. Bone grafting, which accounted for 24 million procedures and $3.3 billion in sales worldwide in 2010, is critical to treat CMF complications associated to trauma, tumour removal, or congenital disorders. However, the use of traditional autogenous or allogenic grafts possesses a number of problems. MINGRAFT aims to establish a new scalable bioactive coating for bespoke implants to treat mandibular bone complications. The project will aim to develop a coating that is tuneable, easy to fabricate, versatile, and that can promote the rapid integration of mandibular implants while stimulating bone regeneration.
Unfold all
/
Fold all
More information & hyperlinks
| Web resources: | https://cordis.europa.eu/project/id/790240 |
| Start date: | 01-02-2020 |
| End date: | 31-08-2021 |
| Total budget - Public funding: | 149 796,00 Euro - 149 796,00 Euro |
Cordis data
Original description
There is great need for more effective bone grafts to treat craniomaxillofacial (CMF) complications. Bone grafting, which accounted for 24 million procedures and $3.3 billion in sales worldwide in 2010, is critical to treat CMF complications associated to trauma, tumour removal, or congenital disorders. However, the use of traditional autogenous or allogenic grafts possesses a number of problems. MINGRAFT aims to establish a new scalable bioactive coating for bespoke implants to treat mandibular bone complications. The project will aim to develop a coating that is tuneable, easy to fabricate, versatile, and that can promote the rapid integration of mandibular implants while stimulating bone regeneration.Status
CLOSEDCall topic
ERC-2017-PoCUpdate Date
27-04-2024
Geographical location(s)
